Inventory Summary of CEL-SCI Corporation

CEL-SCI Corporation's latest annual inventory in 2023 was 2.24 Million USD , up 12.31% from previous year.
CEL-SCI Corporation's latest quarterly inventory in 2024 Q3 was 2.55 Million USD , up 2.65% from previous quarter.
CEL-SCI Corporation reported annual inventory of 2 Million USD in 2022, down -0.24% from previous year.
CEL-SCI Corporation reported annual inventory of 2 Million USD in 2021, up 144.69% from previous year.
CEL-SCI Corporation reported quarterly inventory of 2.48 Million USD for 2024 Q2, up 6.06% from previous quarter.
CEL-SCI Corporation reported quarterly inventory of 2.34 Million USD for 2024 Q1, up 4.4% from previous quarter.

Annual Inventory Chart of CEL-SCI Corporation (2023 - 1989)

Historical Annual Inventory of CEL-SCI Corporation (2023 - 1989)

Year	Inventory	Inventory Growth
2023	2.24 Million USD	12.31%
2022	2 Million USD	-0.24%
2021	2 Million USD	144.69%
2020	820.05 Thousand USD	4.82%
2019	782.36 Thousand USD	21.25%
2018	645.23 Thousand USD	-4.06%
2017	672.52 Thousand USD	-33.32%
2016	1 Million USD	-28.05%
2015	1.4 Million USD	-3.46%
2014	1.45 Million USD	42.83%
2013	1.01 Million USD	-26.57%
2012	1.38 Million USD	-11.88%
2011	1.57 Million USD	6.43%
2010	1.47 Million USD	269.54%
2009	399.47 Thousand USD	1.09%
2008	395.17 Thousand USD	2.47%
2007	385.65 Thousand USD	-1.28%
2006	390.64 Thousand USD	0.0%
2005	- USD	-100.0%
2004	508.59 Thousand USD	42.25%
2003	357.53 Thousand USD	-20.92%
2002	452.12 Thousand USD	0.0%
2001	- USD	0.0%
2000	- USD	0.0%
1999	- USD	0.0%
1998	- USD	0.0%
1997	- USD	0.0%
1996	- USD	0.0%
1995	- USD	0.0%
1994	- USD	0.0%
1993	- USD	0.0%
1992	- USD	0.0%
1991	- USD	0.0%
1990	- USD	0.0%
1989	- USD	0.0%

Year	Inventory	Inventory Growth
2024 Q3	2.55 Million USD	2.65%
2024 Q2	2.48 Million USD	6.06%
2024 Q1	2.34 Million USD	4.4%
2023 Q3	2.1 Million USD	11.42%
2023 Q1	1.84 Million USD	-7.64%
2023 Q2	1.89 Million USD	2.43%
2023 FY	2.24 Million USD	12.31%
2023 Q4	2.24 Million USD	6.54%
2022 Q1	2.06 Million USD	3.05%
2022 Q4	2 Million USD	-7.88%
2022 Q3	2.17 Million USD	8.36%
2022 Q2	2 Million USD	-3.02%
2022 FY	2 Million USD	-0.24%
2021 Q4	2 Million USD	27.06%
2021 Q3	1.57 Million USD	8.25%
2021 Q2	1.45 Million USD	26.54%
2021 Q1	1.15 Million USD	40.58%
2021 FY	2 Million USD	144.69%
2020 Q3	787.01 Thousand USD	-7.36%
2020 FY	820.05 Thousand USD	4.82%
2020 Q1	905.87 Thousand USD	15.79%
2020 Q2	849.54 Thousand USD	-6.22%
2020 Q4	820.05 Thousand USD	4.2%
2019 Q2	761.01 Thousand USD	11.5%
2019 FY	782.36 Thousand USD	21.25%
2019 Q4	782.36 Thousand USD	3.65%
2019 Q3	754.82 Thousand USD	-0.81%
2019 Q1	682.52 Thousand USD	5.78%
2018 Q1	644.74 Thousand USD	-4.13%
2018 FY	645.23 Thousand USD	-4.06%
2018 Q4	645.23 Thousand USD	2.72%
2018 Q3	628.15 Thousand USD	-0.34%
2018 Q2	630.31 Thousand USD	-2.24%
2017 Q2	678.66 Thousand USD	-2.28%
2017 FY	672.52 Thousand USD	-33.32%
2017 Q4	672.52 Thousand USD	2.25%
2017 Q3	657.73 Thousand USD	-3.08%
2017 Q1	694.5 Thousand USD	-31.14%
2016 FY	1 Million USD	-28.05%
2016 Q1	1.34 Million USD	-4.19%
2016 Q2	1.29 Million USD	-3.55%
2016 Q3	1.25 Million USD	-2.77%
2016 Q4	1 Million USD	-19.91%
2015 Q2	1.56 Million USD	26.92%
2015 Q4	1.4 Million USD	-0.97%
2015 Q3	1.41 Million USD	-9.7%
2015 Q1	1.23 Million USD	-14.94%
2015 FY	1.4 Million USD	-3.46%
2014 Q1	1.34 Million USD	32.52%
2014 Q2	1.42 Million USD	5.48%
2014 FY	1.45 Million USD	42.83%
2014 Q4	1.45 Million USD	2.71%
2014 Q3	1.41 Million USD	-0.52%
2013 Q1	1.13 Million USD	-17.88%
2013 Q4	1.01 Million USD	-10.48%
2013 Q3	1.13 Million USD	-11.75%
2013 Q2	1.28 Million USD	13.18%
2013 FY	1.01 Million USD	-26.57%
2012 Q4	1.38 Million USD	0.87%
2012 Q2	1.36 Million USD	-0.14%
2012 Q1	1.37 Million USD	-12.78%
2012 FY	1.38 Million USD	-11.88%
2012 Q3	1.37 Million USD	0.3%
2011 FY	1.57 Million USD	6.43%
2011 Q4	1.57 Million USD	-0.45%
2011 Q3	1.57 Million USD	7.07%
2011 Q2	1.47 Million USD	6.33%
2011 Q1	1.38 Million USD	-6.09%
2010 Q3	1.75 Million USD	72.8%
2010 Q4	1.47 Million USD	-15.74%
2010 FY	1.47 Million USD	269.54%
2010 Q2	1.01 Million USD	82.69%
2010 Q1	554.98 Thousand USD	38.93%
2009 Q3	402.38 Thousand USD	-10.02%
2009 Q1	452.77 Thousand USD	14.58%
2009 Q2	447.19 Thousand USD	-1.23%
2009 Q4	399.47 Thousand USD	-0.72%
2009 FY	399.47 Thousand USD	1.09%
2008 Q1	332.6 Thousand USD	-13.75%
2008 Q2	316.34 Thousand USD	-4.89%
2008 Q3	281.67 Thousand USD	-10.96%
2008 Q4	395.17 Thousand USD	40.3%
2008 FY	395.17 Thousand USD	2.47%
2007 Q1	379.85 Thousand USD	-2.76%
2007 Q2	391.9 Thousand USD	3.17%
2007 FY	385.65 Thousand USD	-1.28%
2007 Q4	385.65 Thousand USD	19.97%
2007 Q3	321.46 Thousand USD	-17.97%
2006 FY	390.64 Thousand USD	0.0%
2006 Q2	440.14 Thousand USD	4.82%
2006 Q4	390.64 Thousand USD	-44.2%
2006 Q3	700.05 Thousand USD	59.05%
2006 Q1	419.9 Thousand USD	0.0%
2005 Q2	423.29 Thousand USD	0.31%
2005 Q4	- USD	-100.0%
2005 FY	- USD	-100.0%
2005 Q1	421.98 Thousand USD	-17.03%
2005 Q3	385.52 Thousand USD	-8.92%
2004 Q3	485.68 Thousand USD	16.18%
2004 Q4	508.59 Thousand USD	4.72%
2004 FY	508.59 Thousand USD	42.25%
2004 Q2	418.05 Thousand USD	18.9%
2004 Q1	351.59 Thousand USD	-1.66%
2003 Q2	384.62 Thousand USD	-3.31%
2003 Q1	397.79 Thousand USD	-12.02%
2003 FY	357.53 Thousand USD	-20.92%
2003 Q4	357.53 Thousand USD	0.51%
2003 Q3	355.71 Thousand USD	-7.52%
2002 Q3	345.9 Thousand USD	-11.0%
2002 Q1	663.1 Thousand USD	0.0%
2002 Q4	452.12 Thousand USD	30.71%
2002 Q2	388.66 Thousand USD	-41.39%
2002 FY	452.12 Thousand USD	0.0%
2001 Q1	- USD	0.0%
2001 Q4	- USD	0.0%
2001 Q3	- USD	0.0%
2001 FY	- USD	0.0%
2001 Q2	- USD	0.0%
2000 Q4	- USD	0.0%
2000 Q1	- USD	0.0%
2000 Q3	- USD	0.0%
2000 FY	- USD	0.0%
2000 Q2	- USD	0.0%
1999 Q4	- USD	0.0%
1999 Q3	- USD	0.0%
1999 Q2	- USD	0.0%
1999 FY	- USD	0.0%
1999 Q1	- USD	0.0%
1998 FY	- USD	0.0%
1998 Q4	- USD	0.0%
1998 Q3	- USD	0.0%
1998 Q2	- USD	0.0%
1998 Q1	- USD	0.0%
1997 Q3	- USD	0.0%
1997 Q1	- USD	0.0%
1997 FY	- USD	0.0%
1997 Q4	- USD	0.0%
1997 Q2	- USD	0.0%
1996 FY	- USD	0.0%
1996 Q2	- USD	0.0%
1996 Q3	- USD	0.0%
1996 Q4	- USD	0.0%
1996 Q1	- USD	0.0%
1995 FY	- USD	0.0%
1995 Q3	200 Thousand USD	0.0%
1995 Q1	- USD	0.0%
1995 Q2	- USD	0.0%
1995 Q4	- USD	-100.0%
1994 FY	- USD	0.0%
1994 Q4	- USD	0.0%
1994 Q3	- USD	0.0%
1994 Q2	- USD	0.0%
1994 Q1	- USD	0.0%
1993 Q3	- USD	0.0%
1993 Q4	- USD	0.0%
1993 FY	- USD	0.0%
1993 Q1	- USD	0.0%
1993 Q2	- USD	0.0%
1992 Q1	- USD	0.0%
1992 Q2	- USD	0.0%
1992 Q3	- USD	0.0%
1992 Q4	- USD	0.0%
1992 FY	- USD	0.0%
1991 FY	- USD	0.0%
1991 Q4	- USD	0.0%
1991 Q2	- USD	0.0%
1991 Q3	- USD	0.0%
1991 Q1	- USD	0.0%
1990 Q2	- USD	0.0%
1990 Q4	- USD	0.0%
1990 FY	- USD	0.0%
1990 Q1	- USD	0.0%
1990 Q3	- USD	0.0%
1989 Q3	- USD	0.0%
1989 Q4	- USD	0.0%
1989 FY	- USD	0.0%
1989 Q1	- USD	0.0%

Peer Inventory Comparison of CEL-SCI Corporation

Name	Inventory	Inventory Difference
AIM ImmunoTech Inc.	-1.18 Million USD	289.871%
Ampio Pharmaceuticals, Inc.	1.00 USD	-224807100.0%
Armata Pharmaceuticals, Inc.	- USD	-Infinity%
Actinium Pharmaceuticals, Inc.	- USD	-Infinity%
Azitra, Inc.	-215.21 Thousand USD	1144.551%
Can-Fite BioPharma Ltd.	- USD	-Infinity%
Chromocell Therapeutics Corporation	- USD	-Infinity%
Calidi Biotherapeutics, Inc.	- USD	-Infinity%
iBio, Inc.	- USD	-Infinity%
Lineage Cell Therapeutics, Inc.	- USD	-Infinity%
MAIA Biotechnology, Inc.	- USD	-Infinity%
Matinas BioPharma Holdings, Inc.	- USD	-Infinity%
Navidea Biopharmaceuticals, Inc.	427.34 Thousand USD	-426.057%
NovaBay Pharmaceuticals, Inc.	2.87 Million USD	21.861%
NanoViricides, Inc.	- USD	-Infinity%
Oragenics, Inc.	- USD	-Infinity%
BiomX Inc.	- USD	-Infinity%
BiomX Inc.	- USD	-Infinity%
Protalix BioTherapeutics, Inc.	19.04 Million USD	88.196%
Palatin Technologies, Inc.	- USD	-Infinity%
Scorpius Holdings, Inc.	909.15 Thousand USD	-147.27%
Theriva Biologics, Inc.	- USD	-Infinity%

Global Stocks Search

CEL-SCI Corporation (CVM)

Inventory Summary of CEL-SCI Corporation

Annual Inventory Chart of CEL-SCI Corporation (2023 - 1989)

Historical Annual Inventory of CEL-SCI Corporation (2023 - 1989)

Peer Inventory Comparison of CEL-SCI Corporation